NK
LinkedIn

Najat Khan, PhD

Chief Executive Officer & President | Member, Board of Directors

New York, New York, United States · 1 connection

Recursion

Not on Unlinked · Imported profile. Is this you? Claim it

About

Najat Khan, Ph.D., is an accomplished biopharma leader at the forefront of driving bold innovation to bring transformative therapies to patients. Building on a track record of integrating science, AI/data science, and business leadership across both large pharma and emerging TechBio, she serves as CEO, President, and Board Member at Recursion, where she is advancing an AI-native approach to discovering, developing, and delivering novel medicines to address unmet patient needs. At Recursion, Dr. Khan has combined bold vision with disciplined leadership to advance value and impact. She has sharpened the company’s portfolio and optimized resource allocation across its pipeline and operations – prioritizing and progressing multiple first-in-class and best-in-class clinical programs in oncology, rare disease, neuroscience, and inflammation & immunology, both internally and with biopharma partners. Dr. Khan also helped lead Recursion’s M&A combination with Exscientia – the largest TechBio deal of 2024 – and has expanded the Recursion OS 2.0 platform into an end-to-end engine for drug discovery and development, spanning biology, chemistry, and ClinTech. She has helped build a world-class

Experience

Chief Executive Officer & President | Member, Board of DirectorsRecursion
Jan 2026
Chief R&D Officer and Chief Commercial Officer | Member, Board of DirectorsRecursion
Jul 2024 to Dec 2025
Advisory Board Member, Penn's Vagelos Life Sciences and Management ProgramUniversity of Pennsylvania
Apr 2022
Graduate Research StudentUniversity of Pennsylvania
Aug 2006 to May 2011
Project ManagerUniversity of Pennsylvania
Sep 2009 to Dec 2009
Teaching FellowUniversity of Pennsylvania
Sep 2006 to Aug 2008
Steering Committee MemberCancerX
Sep 2023 to Nov 2024
Former Chief Data Science Officer & SVP/Global Head, Strategy & Portfolio Organization R&D, J&JJohnson & Johnson
May 2020 to May 2024
Co-chair, Johnson and Johnson Data Science CouncilJohnson & Johnson
Feb 2020 to May 2024
Chief Data Science Officer + SVP / Global Head, Strategy, & Operations, R&D, Janssen, J&JJohnson & Johnson
May 2020 to Jun 2023
Chief Operating Officer, Janssen R&D Data Sciences; Global Head, Janssen R&D Strategy and OperationsJohnson & Johnson
Dec 2019 to May 2020
Global Head, Janssen R&D Strategy and Operations; Co-chair, J&J Enterprise Data Science CouncilJohnson & Johnson
Apr 2019 to Dec 2019
Head, R&D Strategic InitiativesJohnson & Johnson
Mar 2018 to Mar 2019
MemberChief
Jan 2020 to May 2024
PartnerBoston Consulting Group (BCG)
Aug 2011 to Feb 2018
Chemistry Department Representative; Administrative and Policy Committee MemberUniversity of Pennsylvania, School of Arts and Sciences (SASgov) Basic company page — company details not listed yet
Mar 2008 to Dec 2009

Education

University of Pennsylvania
Ph.D., Organic Chemistry (with a computational chemistry focus)
Massachusetts Institute of Technology
AI / Machine Learning (MIT Computer Science & Artificial Intelligence Laboratory (CSAIL)
Colgate University
Bachelors, Computational Chemistry (Chemistry and Computer Science), Economics